<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/~/media/Files/S/staar-surgical/XSL/rss_xsl.xsl"?> 
<rss version="2.0" xmlns:dt="http://xsltsl.org/date-time">
 <channel>
  <title>RSS - Staar Surgical - Press Releases </title>
  <link>https://investors.staar.com/rss/press-releases</link>
  <language>en</language>
<webMaster>Staar Surgical</webMaster>
<image>
<url>https://investors.staar.com/~/media/Images/S/staar-surgical/logo/logo-dark.svg</url>
</image>
<item>
<title><![CDATA[STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction]]></title>
<description><![CDATA[The report examines patient sentiment, procedure volume trends, and clinical practice patterns across Japan, China, South Korea, the United States, Germany, Spain, and the UK and Ireland. The STAAR Surgical team will be available to discuss the results of the report at the upcoming 44th Congress of the ESCRS in London from September 11– 15, 2026, where the Company...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-10-2026-120022923</link>
<pubDate>Thu, 10 Sep 2026 12:00:00 GMT</pubDate>
<publishDate>Thu, 10 Sep 2026 12:00:25 GMT</publishDate>
<guid>{883CA235-B69A-47D1-8840-E3242E791C70}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer.  "As our former President and CEO, he launched commercialization of the ICL across Asia and championed development of the central port, the innovation...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-08-2026-203320099</link>
<pubDate>Tue, 08 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 09 Sep 2026 20:33:21 GMT</publishDate>
<guid>{7175C232-331D-41E3-94C7-0A2FC2B86B55}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of Ben Park, Ph.D., as Chief Technology Officer. Park will join STAAR's Executive Committee and report to Warren Foust, President and Chief Executive Officer. Park built and led a global...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-02-2026-210122542</link>
<pubDate>Wed, 02 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 02 Sep 2026 21:01:25 GMT</publishDate>
<guid>{8F9699E1-BDB3-4A95-929B-82C729BE9E03}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Reports Second Quarter 2026 Results]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today reported results for the second quarter ended July 3, 2026.. Second Quarter 2026 Financial Overview. Net sales of $93.5 million, up 111% Y/Y Net sales excluding China of $41.2 million, up 6.0% Y/Y China sales of $52.3 million...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-12-2026-210127260</link>
<pubDate>Wed, 12 Aug 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 12 Aug 2026 21:02:53 GMT</publishDate>
<guid>{A7330ED6-4D06-4427-9D07-6000A947FF43}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that following an extensive global search, its Board of Directors has appointed Warren Foust as President and Chief Executive Officer and a new member of the Board of Directors, effective August 4, 2026.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-04-2026-210656803</link>
<pubDate>Tue, 04 Aug 2026 21:05:00 GMT</pubDate>
<publishDate>Tue, 04 Aug 2026 21:07:56 GMT</publishDate>
<guid>{38D87318-50C8-44FF-8848-525AF8A87B2C}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results in combination with a shareholder letter for the second quarter ended July 3, 2026, on Wednesday, August 12, 2026, after the market close. The Company will also host an...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-04-2026-210126674</link>
<pubDate>Tue, 04 Aug 2026 21:01:00 GMT</pubDate>
<publishDate>Tue, 04 Aug 2026 21:02:53 GMT</publishDate>
<guid>{EFE4D4D6-0AC5-47BD-91D7-ACA2CEDE6994}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026]]></title>
<description><![CDATA[The Company delivered strong second quarter net sales, led by sequential growth in China, solid growth across the broader Asia-Pacific region, and double-digit percentage growth in the Americas. In the EMEA region, net sales declined by a low single-digit percentage, reflecting ongoing turmoil in the Middle East; however, excluding the Middle East, EMEA...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/07-16-2026-210120790</link>
<pubDate>Thu, 16 Jul 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 16 Jul 2026 21:01:23 GMT</publishDate>
<guid>{EE4E22A0-D6E9-42F4-94BF-B9746671EA03}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Announces Participation in Upcoming Investor Conferences]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that management will participate in the following upcoming conferences:. Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/05-21-2026-210114255</link>
<pubDate>Thu, 21 May 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 21 May 2026 21:02:52 GMT</publishDate>
<guid>{0256C7AA-F48A-4846-87C3-7BA4FA5BD078}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today reported results for the first quarter ended April 3, 2026.. Net sales of $93.5 million, up 119.6% Y/Y Net sales excluding China of $46.1 million, up 6.0% Y/Y Gross margin at 73.6% vs. 65.8% a year ago Net income of $5.2 million...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/05-13-2026-210133481</link>
<pubDate>Wed, 13 May 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 13 May 2026 21:06:47 GMT</publishDate>
<guid>{20625DC0-0CEC-47A4-AB46-BEDEF46DC84A}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results in combination with a shareholder letter for the first quarter ended April 3, 2026, on Wednesday, May 13, 2026, after the market close. The Company will also host an...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/05-04-2026-210121992</link>
<pubDate>Mon, 04 May 2026 21:01:00 GMT</pubDate>
<publishDate>Mon, 04 May 2026 21:01:22 GMT</publishDate>
<guid>{FFADCD1C-B797-4EA6-A8A3-8B1FAE2BAE3A}</guid>
<isalertable>False</isalertable>
</item>

  
 </channel>
</rss>